ACCELERON PHARMA INC XLRN
COM · Common Stock · CUSIP 00434H108 · ISIN US00434H1086
1
institutional holders
-334 vs Q3 2021
2
shares reported held*
$0reported value*
0 new
0 added
1 reduced
321 sold out
net sold ≈ $8.7bn (-50.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 184 |
| Q1 2020 | 218 |
| Q2 2020 | 244 |
| Q3 2020 | 239 |
| Q4 2020 | 256 |
| Q1 2021 | 258 |
| Q2 2021 | 273 |
| Q3 2021 | 335 |
| Q4 2021 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 111 | 106 |
| Q2 2020 | 141 | 95 |
| Q3 2020 | 142 | 120 |
| Q4 2020 | 116 | 111 |
| Q1 2021 | 114 | 123 |
| Q2 2021 | 135 | 109 |
| Q3 2021 | 179 | 139 |
| Q4 2021 | 0 | 322 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q1 2021 | $33.7m | $44.8m | 1.33 |
| Q2 2021 | $24.9m | $43.9m | 1.76 |
| Q3 2021 | $588.9m | $208.5m | 0.35 |
| Q4 2021 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| PRICE T ROWE ASSOCIATES INC /MD/ | Sold out | -5.4m |
| VANGUARD GROUP INC | Sold out | -4.9m |
| Avoro Capital Advisors LLC | Sold out | -4.0m |
| BlackRock Inc. | Sold out | -4.0m |
| FMR LLC | Sold out | -2.1m |
| Darwin Global Management, Ltd. | Sold out | -2.0m |
| JANUS HENDERSON GROUP PLC | Sold out | -1.6m |
| BAMCO INC /NY/ | Sold out | -1.3m |
| ALKEON CAPITAL MANAGEMENT LLC | Sold out | -1.2m |
| STATE STREET CORP | Sold out | -1.2m |
Holders, Q4 2021
| Manager | Shares | Change |
|---|---|---|
| HUNTINGTON NATIONAL BANK 0.00% of their portfolio | 2 $0 | Reduced -55 |